HomeCompareCI vs SYK

CI vs SYK: Dividend Comparison 2026

CI yields 2.36% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CI wins by $133.44M in total portfolio value
10 years
CI
CI
● Live price
2.36%
Share price
$258.08
Annual div
$6.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$133.48M
Annual income
$123,432,595.24
Full CI calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — CI vs SYK

📍 CI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCISYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CI + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CI pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CI
Annual income on $10K today (after 15% tax)
$200.58/yr
After 10yr DRIP, annual income (after tax)
$104,917,705.95/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, CI beats the other by $104,910,665.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CI + SYK for your $10,000?

CI: 50%SYK: 50%
100% SYK50/50100% CI
Portfolio after 10yr
$66.76M
Annual income
$61,720,439.11/yr
Blended yield
92.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

CI
Analyst Ratings
1
Strong
31
Buy
7
Hold
Consensus: Buy
Price Target
$325.83
+26.3% upside vs current
Range: $300.00 — $375.00
Altman Z
2.7
Piotroski
7/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CI buys
9
SYK buys
0
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$CI▲ Buy$1,001 - $15,0002025-09-05
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$CI▼ Sell$1,001 - $15,0002025-08-05
Jared Moskowitz🏢 House$CI▲ Buy$1,001 - $15,0002025-05-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCISYK
Forward yield2.36%1.04%
Annual dividend / share$6.09$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%46.2%
Portfolio after 10y$133.48M$43.3K
Annual income after 10y$123,432,595.24$8,282.98
Total dividends collected$132.70M$21.0K
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare
Analyst consensusBuyBuy
Analyst price target$325.83$428.67

Year-by-year: CI vs SYK ($10,000, DRIP)

YearCI PortfolioCI Income/yrSYK PortfolioSYK Income/yrGap
1← crossover$11,172$471.95$10,852$152.43+$320.00CI
2$12,940$985.53$11,838$226.03+$1.1KCI
3$15,979$2,133.55$13,004$336.89+$3.0KCI
4$22,022$4,924.66$14,420$505.63+$7.6KCI
5$36,250$12,686.29$16,195$766.09+$20.1KCI
6$77,820$39,032.84$18,504$1,175.64+$59.3KCI
7$239,893$156,625.47$21,635$1,835.40+$218.3KCI
8$1,159,158$902,472.79$26,082$2,932.10+$1.13MCI
9$9,391,197$8,150,897.78$32,737$4,829.68+$9.36MCI
10$133,481,176$123,432,595.24$43,312$8,282.98+$133.44MCI

CI vs SYK: Complete Analysis 2026

CIHealthcare

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Full CI Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this CI vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CI vs SCHDCI vs JEPICI vs OCI vs KOCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.